IPO
-
-
-
-
-
-
-
CRISPR Therapeutics (CRSP) Reports Patent for CRISPR/Cas Genome Editing in China
-
-
-
-
-
-
-
CRISPR (CRSP), Intellia (NTLA), Caribou, ERS Genomics Provide Update on CRISPR/Cas9 U.S. Patent Interference Proceedings
-
-
-
-
-
118,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

